EXCELLON REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS

Stock Information for Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Excellon Announces Filing of Technical Report Regarding La Negra Mine in Mexico
ThriveDX and Exclusive Networks Unveil Strategic Plan to Bridge the Cyber Talent Shortage and Skills Gap in Europe
Excellon common shares to be delisted from NYSE American
EXCELLON ANNOUNCES AGREEMENT TO ACQUIRE PAST PRODUCING LA NEGRA MINE IN MEXICO
EXCELLON INTERCEPTS 115 METERS @ 0.74 G/T AU AT KILGORE
ThriveDX, Exclusive Networks Partner to Address the Global Cybersecurity Talent Shortage & Skills Gap
Excellon Looks to Spin-Out Globex's Silver City Property in Saxony, Germany
EXCELLON PROVIDES CORPORATE UPDATE

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.